Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs"

被引：2
|
作者：
Su, I-Hsuan [1 ]
Lund, Jennifer L. [1 ,2 ]
Gaber, Charles E. [3 ]
Sanoff, Hanna K. [2 ,4 ]
Strassle, Paula D. [5 ]
Duchesneau, Emilie D. [1 ,2 ]
机构：
[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[3] Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
[4] Univ N Carolina, Dept Med, Div Oncol, Chapel Hill, NC 27515 USA
[5] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, NIH, Bethesda, MD USA
来源：
ONCOLOGIST | 2023年 / 28卷 / 07期
关键词：
BIAS;
D O I：
10.1093/oncolo/oyad130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E588 / E589
页数：2
相关论文
共 50 条
  • [41] Adjuvant chemotherapy versus observation following neoadjuvant therapy and surgery for resectable stages I-II pancreatic cancer
    Ma, Sung Jun
    Serra, Lucas M.
    Bartl, Austin J.
    Han, Hye Ri
    Fekrmandi, Fatemeh
    Iovoli, Austin J.
    Hermann, Gregory M.
    Yu, Han
    Singh, Anurag K.
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2022, 21 (03) : 383 - 392
  • [42] CHEMOTHERAPY FOR INVASIVE BLADDER-CANCER - NEOADJUVANT VERSUS ADJUVANT
    SCHER, HI
    SEMINARS IN ONCOLOGY, 1990, 17 (05) : 555 - 565
  • [43] Neoadjuvant Versus Adjuvant Chemotherapy for Triple Negative Breast Cancer
    Kennedy, Carlie R.
    Gao, Feng
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2010, 163 (01) : 52 - 57
  • [44] Adjuvant Chemotherapy Versus Observation Following Neoadjuvant Therapy and Surgery for Resectable Stage I-II Pancreatic Cancer
    Ma, S. J.
    Oladeru, O. T.
    Miccio, J. A.
    Iovoli, A. J.
    Hermann, G. M.
    Singh, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E240 - E240
  • [45] Is There a Survival Benefit to Neoadjuvant Versus Adjuvant Chemotherapy, Combined with Surgery for Resectable Colorectal Liver Metastases?
    Lubezky, Nir
    Geva, Ravit
    Shmueli, Einat
    Nakache, Richard
    Klausner, Joseph M.
    Figer, Arie
    Ben-Haim, Menahem
    WORLD JOURNAL OF SURGERY, 2009, 33 (05) : 1028 - 1034
  • [46] Is There a Survival Benefit to Neoadjuvant Versus Adjuvant Chemotherapy, Combined with Surgery for Resectable Colorectal Liver Metastases?
    Nir Lubezky
    Ravit Geva
    Einat Shmueli
    Richard Nakache
    Joseph M. Klausner
    Arie Figer
    Menahem Ben-Haim
    World Journal of Surgery, 2009, 33 : 1028 - 1034
  • [47] Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer
    Hebbar, Mohamed
    Pruvot, Francois-Rene
    Romano, Olivier
    Triboulet, Jean-Pierre
    de Gramont, Aimery
    CANCER TREATMENT REVIEWS, 2009, 35 (08) : 668 - 675
  • [48] An evaluation of adjuvant chemotherapy following neoadjuvant chemotherapy and resection for borderline resectable and locally advanced pancreatic cancer
    Zhang, Chunmeng
    Wu, Ruiqian
    Smith, Lynette M.
    Baine, Michael
    Lin, Chi
    Reames, Bradley N.
    AMERICAN JOURNAL OF SURGERY, 2022, 224 (01): : 51 - 57
  • [49] Neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Finkelstein, EI
    Urschel, JD
    Takita, H
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1997, 16 (04) : 437 - 439
  • [50] Neoadjuvant Chemotherapy for Resectable Non-Small-Cell Lung Cancer
    Gray, Jhanelle
    Sommers, Eric
    Alvelo-Rivera, Miguel
    Robinson, Lary
    Bepler, Gerold
    ONCOLOGY-NEW YORK, 2009, 23 (10): : 879 - 886
12345